Publication | Closed Access

OA02.03 Clinical Activity of Lorlatinib in Patients with ROS1+ Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6

Study Cohort Exp-6MedicinePathologyBronchial NeoplasmCancer TreatmentPhase 2Oa02.03 Clinical ActivityOncologyRadiation OncologyCancer ResearchLung CancerMolecular OncologyCancer Growth